Hanlon Suzanne M. 4
4 · Zynerba Pharmaceuticals, Inc. · Filed Jan 25, 2021
Insider Transaction Report
Form 4
Hanlon Suzanne M.
General Counsel
Transactions
- Award
Common Stock
2021-01-21+37,000→ 80,693 total - Award
Stock Option (right to buy)
2021-01-21+55,000→ 55,000 totalExercise: $3.58Exp: 2031-01-21→ Common Stock (55,000 underlying)
Footnotes (2)
- [F1]These restricted stock units will fully vest on January 21, 2023, subject to continued employment with the Company through the applicable vesting date.
- [F2]The stock option vests 25% on the first anniversary of the date of the grant, with the remainder vesting in 12 equal quarterly installments thereafter, subject to continued employment with the Company through the applicable vesting date.